2011
DOI: 10.1128/aac.00436-10
|View full text |Cite
|
Sign up to set email alerts
|

In Silico Screening, Structure-Activity Relationship, and Biologic Evaluation of Selective Pteridine Reductase Inhibitors Targeting Visceral Leishmaniasis

Abstract: In this study we utilized the concept of rational drug design to identify novel compounds with optimal selectivity, efficacy and safety, which would bind to the target enzyme pteridine reductase 1 (PTR1) in Leishmania parasites. Twelve compounds afforded from Baylis-Hillman chemistry were docked by using the QUANTUM program into the active site of Leishmania donovani PTR1 homology model. The biological activity for these compounds was estimated in green fluorescent protein-transfected L. donovani promastigotes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(17 citation statements)
references
References 23 publications
(22 reference statements)
1
16
0
Order By: Relevance
“…In silico protein analysis has received great attention lately, with particular emphasis in finding suitable biomarkers for the diagnosis of infectious or noninfectious diseases, identification of different pathogenic genera (Kumar, Koul, Kumar, & Kalia, ), new drug development (Kaur et al, ) and for the discovery of potent bioactive peptides and proteins with potential biotechnological use (N. Singh & Kashyap, ). Phyre2 is one of the most widely used protein structure prediction servers, processing approximately 700–1,000 user‐submitted proteins per day (Kelley et al, ).…”
Section: Discussionmentioning
confidence: 99%
“…In silico protein analysis has received great attention lately, with particular emphasis in finding suitable biomarkers for the diagnosis of infectious or noninfectious diseases, identification of different pathogenic genera (Kumar, Koul, Kumar, & Kalia, ), new drug development (Kaur et al, ) and for the discovery of potent bioactive peptides and proteins with potential biotechnological use (N. Singh & Kashyap, ). Phyre2 is one of the most widely used protein structure prediction servers, processing approximately 700–1,000 user‐submitted proteins per day (Kelley et al, ).…”
Section: Discussionmentioning
confidence: 99%
“…The J774A.1 mouse (BALB/c) macrophage cell line was obtained from the National Centre for Cell Science (Pune, India) and used as a cellular host for the in vitro intracellular test of antileishmanial activity against amastigotes. The cells were maintained in RPMI 1640 medium (Gibco-BRL) adjusted to contain 2 g of sodium bicarbonate/ liter, 6 g of HEPES/liter, 10% (vol/vol) heat-inactivated fetal bovine serum (HI-FBS; Gibco, Germany), and 100 U penicillin and 100 g of streptomycin/ml at 37°C in a humidified atmosphere of 95% air and 5% CO 2 (26).…”
Section: Synthesis Of Ag Nps and Tiomentioning
confidence: 99%
“…The "in-silico" analysis which stands for computer-based biological experiments, is a state-of-the-art and accurate method to discover exclusive bioactive compounds, which may represent novel metabolic pathways and/or a powerful affinity to a certain target (42). In this sense, several studies have identified unprecedented molecules for various drug targets in Leishmania, such as pteridine reductase1, tryparedoxin peroxidase and sterol biosynthesis (43)(44)(45)(46)(47)(48), as well as in other single-celled eukaryotes enclosing Toxoplasma gondii, Cryptosporidium hominis, Plasmodium and Trypanosoma cruzi (49)(50)(51). Current in-silico investigation was aimed to screen and predict the anti-leishmanial potency of 3358 FDA-approved compounds against both drug targets in L. infantum in comparison to amphotericin B and glucantime for the discovery of new biochemical molecules.…”
Section: Discussionmentioning
confidence: 99%